Pharmacists Bridging the Gap and Optimizing Care for Substance Use Disorder Patients
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (30 June 2017) | Viewed by 192
Special Issue Editor
Special Issue Information
Dear Colleagues,
There has been a recent epidemic of opioid-related deaths and patients diagnosed with substance use disorders. While pharmacotherapy has been shown to be effective in preventing relapse, there is a clear gap in treatment availability. Pharmacists can play an essential part in managing patients with substance use disorders. We are in the process of creating a Special Issue of Pharmacy on the role of the pharmacists in the management of substance use disorders and how this profession can help to bridge the workforce gap. The publications will highlight practice descriptions, treatment dilemmas, optimization of care, and recommendations for overcoming barriers.
Pharmacy is a peer-reviewed, scientific, open access journal on pharmacy education and practice, published quarterly online by MDPI. We would like to offer you the opportunity to publish a paper describing your work free of charge. The article should incorporate a detailed description of your practice development and/or pharmacy services and include outcomes or other relevant data, when available. The collection will be published online to help pharmacists in establishing or improving their current practice. It will emphasize the integral role that pharmacists play in this field.
Prof. Dr. Bethany DiPaula, PharmD, BCPP
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Pharmacist
- Substance Use Disorder
- Substance Abuse
- Addiction
- Opioid Use Disorder
- Opioid Overdose
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
